Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis.
Purity:
95.00%
CAS Number:
[909395-70-6]
Target:
Wnt/beta-catenin
* VAT and and shipping costs not included. Errors and price changes excepted